Clinical Trial Update: Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of eflornithine and temozolomide in newly diagnosed glioblastoma or astrocytoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma

Drugs mentioned

• Eflornithine (eflornithine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Orbus Therapeutics, Inc. | Conditions: Glioblastoma, IDH-wildtype, Glioblastoma | Phase 1 | Status: RECRUITING